JP7811578B2 - 中環状または大環状ベンジル置換複素環誘導体およびオレキシン-2受容体アゴニストとしてのそれらの使用 - Google Patents
中環状または大環状ベンジル置換複素環誘導体およびオレキシン-2受容体アゴニストとしてのそれらの使用Info
- Publication number
- JP7811578B2 JP7811578B2 JP2023515095A JP2023515095A JP7811578B2 JP 7811578 B2 JP7811578 B2 JP 7811578B2 JP 2023515095 A JP2023515095 A JP 2023515095A JP 2023515095 A JP2023515095 A JP 2023515095A JP 7811578 B2 JP7811578 B2 JP 7811578B2
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- compound
- alkenyl
- optionally substituted
- present disclosure
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
- C07D487/14—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
- C07D487/18—Bridged systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D498/14—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D498/18—Bridged systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063074220P | 2020-09-03 | 2020-09-03 | |
| US63/074,220 | 2020-09-03 | ||
| PCT/US2021/049003 WO2022051583A1 (en) | 2020-09-03 | 2021-09-03 | Medium- or macro-cyclic benzyl-substituted heterocycle derivatives and their uses as orexin-2 receptor agonists |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023540350A JP2023540350A (ja) | 2023-09-22 |
| JP2023540350A5 JP2023540350A5 (cg-RX-API-DMAC7.html) | 2024-10-02 |
| JP7811578B2 true JP7811578B2 (ja) | 2026-02-05 |
Family
ID=78078371
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023515095A Active JP7811578B2 (ja) | 2020-09-03 | 2021-09-03 | 中環状または大環状ベンジル置換複素環誘導体およびオレキシン-2受容体アゴニストとしてのそれらの使用 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20230331720A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4208465A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP7811578B2 (cg-RX-API-DMAC7.html) |
| CN (1) | CN116635393A (cg-RX-API-DMAC7.html) |
| TW (1) | TW202227433A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2022051583A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20260083444A (ko) | 2019-11-25 | 2026-06-05 | 알케르메스,인코포레이티드 | 치환된 마크로사이클릭 화합물 및 관련 치료 방법 |
| US12503475B2 (en) | 2020-09-03 | 2025-12-23 | Centessa Pharmaceuticals (Uk) Limited | Bicyclic-heterocycle derivatives and their uses as orexin-2 receptor agonists |
| US12006330B2 (en) | 2020-12-21 | 2024-06-11 | Alkermes, Inc. | Substituted macrocyclic compounds and related methods of treatment |
| US11760747B2 (en) | 2020-12-21 | 2023-09-19 | Alkermes, Inc. | Substituted piperidino compounds and related methods of treatment |
| WO2022207935A1 (en) | 2021-04-02 | 2022-10-06 | Orexia Therapeutics Limited | 2-(3-ethynylbenzyl)-substituted heterocycle derivatives as orexin-2 agonists |
| JP7833486B2 (ja) * | 2021-05-26 | 2026-03-19 | アルカーメス,インコーポレイテッド | 置換されるカルバメート大環状化合物および関連のある治療方法 |
| WO2023167925A1 (en) * | 2022-03-01 | 2023-09-07 | Orexia Therapeutics Limited | Medium- or macro-cyclic benzyl-substituted heterocycle derivatives and related uses |
| US20260116891A1 (en) * | 2022-04-22 | 2026-04-30 | Teijin Pharma Limited | Oxazepin Derivative |
| CN114716319B (zh) * | 2022-04-28 | 2024-03-26 | 浙江工业大学 | 一种联芳氧基烯酸酯类化合物的合成方法 |
| EP4600242A1 (en) * | 2022-10-07 | 2025-08-13 | Kissei Pharmaceutical Co., Ltd. | Cyclopentane compound |
| TW202432109A (zh) | 2022-10-31 | 2024-08-16 | 日商武田藥品工業股份有限公司 | 食慾素2型受體促效劑之給藥 |
| EP4680611A1 (en) | 2023-03-16 | 2026-01-21 | Takeda Pharmaceutical Company Limited | Macrocyclic heterocycle compounds and use thereof |
| JP2026518313A (ja) | 2023-06-01 | 2026-06-04 | ハー・ルンドベック・アクチエゼルスカベット | スピロ大環状オレキシン2受容体アゴニスト |
| TW202502342A (zh) | 2023-06-02 | 2025-01-16 | 日商武田藥品工業股份有限公司 | 食慾素2受體促效劑用於改善睡眠期間之呼吸功能的用途 |
| UY40937A (es) * | 2023-10-20 | 2025-04-30 | Teijin Pharma Ltd | Cristal de derivado de oxazepina o cristal de solvato del mismo |
| CN122374291A (zh) | 2023-12-12 | 2026-07-10 | 爱杜西亚药品有限公司 | 作为食欲素受体调节剂的芳基砜及砜酮衍生物 |
| WO2025132542A1 (en) | 2023-12-19 | 2025-06-26 | Idorsia Pharmaceuticals Ltd | Macrocyclic orexin agonists |
| WO2025229493A1 (en) | 2024-04-29 | 2025-11-06 | Takeda Pharmaceutical Company Limited | Dosing of orexin type 2 receptor agonists |
| US20260144795A1 (en) | 2024-11-27 | 2026-05-28 | H. Lundbeck A/S | Spiromacrocyclic orexin 2 receptor agonists |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2019527688A (ja) | 2017-08-03 | 2019-10-03 | 武田薬品工業株式会社 | 複素環化合物およびその用途 |
| WO2020158958A1 (en) | 2019-01-31 | 2020-08-06 | Takeda Pharmaceutical Company Limited | Heterocyclic compound and use thereof |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4522811A (en) | 1982-07-08 | 1985-06-11 | Syntex (U.S.A.) Inc. | Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides |
| US5763263A (en) | 1995-11-27 | 1998-06-09 | Dehlinger; Peter J. | Method and apparatus for producing position addressable combinatorial libraries |
| PE20081229A1 (es) * | 2006-12-01 | 2008-08-28 | Merck & Co Inc | Antagonistas de receptor de orexina de diazepam sustituido |
| KR20260083444A (ko) * | 2019-11-25 | 2026-06-05 | 알케르메스,인코포레이티드 | 치환된 마크로사이클릭 화합물 및 관련 치료 방법 |
-
2021
- 2021-09-03 CN CN202180074185.9A patent/CN116635393A/zh active Pending
- 2021-09-03 US US18/024,236 patent/US20230331720A1/en active Pending
- 2021-09-03 JP JP2023515095A patent/JP7811578B2/ja active Active
- 2021-09-03 EP EP21786656.5A patent/EP4208465A1/en active Pending
- 2021-09-03 TW TW110132882A patent/TW202227433A/zh unknown
- 2021-09-03 WO PCT/US2021/049003 patent/WO2022051583A1/en not_active Ceased
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2019527688A (ja) | 2017-08-03 | 2019-10-03 | 武田薬品工業株式会社 | 複素環化合物およびその用途 |
| WO2020158958A1 (en) | 2019-01-31 | 2020-08-06 | Takeda Pharmaceutical Company Limited | Heterocyclic compound and use thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2022051583A1 (en) | 2022-03-10 |
| EP4208465A1 (en) | 2023-07-12 |
| JP2023540350A (ja) | 2023-09-22 |
| CN116635393A (zh) | 2023-08-22 |
| TW202227433A (zh) | 2022-07-16 |
| US20230331720A1 (en) | 2023-10-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023540350A (ja) | 中環状または大環状ベンジル置換複素環誘導体およびオレキシン-2受容体アゴニストとしてのそれらの使用 | |
| JP7840517B2 (ja) | 二環式複素環誘導体およびオレキシン-2受容体アゴニストとしてのそれらの使用 | |
| WO2022268230A1 (zh) | 作为kif18a抑制剂的化合物 | |
| CN114641473A (zh) | Brd9双官能团降解剂及其使用方法 | |
| WO2024083256A1 (zh) | pan-KRAS降解剂及其制备方法和应用 | |
| CN115836072A (zh) | Kras g12c蛋白的抑制剂和其用途 | |
| JP2023534983A (ja) | テトラヒドロピラゾロ-ピラジニル-ジヒドロイミダゾロンまたはテトラヒドロピラゾロ-ピリジニル-ジヒドロイミダゾロン化合物およびそれを使用する方法 | |
| CN113272301A (zh) | 杂环类化合物、中间体、其制备方法及应用 | |
| JP6532599B2 (ja) | ブロモドメイン阻害薬としての使用のためのピリジノンジカルボキサミド | |
| CN115768772A (zh) | 作为用于治疗α-1抗胰蛋白酶缺乏症(AATD)的α-1抗胰蛋白酶调节剂的吡喃并[4,3-b]L吲哚衍生物 | |
| CN101094848A (zh) | 有机化合物 | |
| US20250236629A1 (en) | Medium- or macro-cyclic benzyl-substituted heterocycle derivatives and related uses | |
| TW201706275A (zh) | 具有hiv複製抑制作用之含氮3環性衍生物 | |
| JP6954921B2 (ja) | ブロモドメイン阻害薬としてのピリジル誘導体 | |
| CN117042769A (zh) | 作为布鲁顿酪氨酸激酶(btk)降解剂的取代的吡咯并嘧啶和吡唑并嘧啶 | |
| CN113754654A (zh) | 咪唑并吡啶类化合物及其用途 | |
| CN114874209B (zh) | 噁二唑瞬时受体电位通道抑制剂 | |
| WO2020063824A1 (zh) | 硝羟喹啉前药及其用途 | |
| WO2020192652A1 (zh) | 酰胺类化合物制备方法及其在医药领域的应用 | |
| WO2024125627A1 (zh) | 喜树碱类化合物及其制备方法和用途 | |
| WO2025108255A1 (zh) | 一种多环类衍生物、其制备方法和应用 | |
| TW202430522A (zh) | 一種用於bcl-2蛋白靶向降解的嵌合體化合物、其製備方法及其在醫藥上的應用 | |
| TW202333663A (zh) | Rxfp1促效劑 | |
| WO2025067239A1 (zh) | 驱动蛋白kif18a抑制剂及其应用 | |
| CN106458987B (zh) | 用于治疗疾病诸如糖尿病的吡咯烷gpr40调节剂 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20230413 |
|
| RD04 | Notification of resignation of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7424 Effective date: 20230519 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20230816 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20240902 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20240902 |
|
| RD03 | Notification of appointment of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7423 Effective date: 20240902 |
|
| RD04 | Notification of resignation of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7424 Effective date: 20240904 |
|
| A711 | Notification of change in applicant |
Free format text: JAPANESE INTERMEDIATE CODE: A711 Effective date: 20241226 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20241226 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20250715 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20250724 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20251015 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20251224 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20260123 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20260126 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 7811578 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |